Robinson Pharma Implements New Equipment to Meet Growing Demand for Vegetarian Supplements

Robinson Pharma Inc., a nutraceutical manufacturer, has announced the continued growth of its operations with the opening of a new facility in Santa Ana, California. This milestone underscores the company's commitment to innovation within the supplement manufacturing industry.

The company operates nine cGMP-certified facilities with over 1,000,000 square feet of total production space, setting a benchmark for quality and capacity in the dietary supplement sector. This strategic expansion aims to meet the growing global demand for high-quality nutraceutical production.

The flagship facility, with a capacity of 138,000 square feet, houses 36 advanced softgel encapsulation machines, including 15 specifically designated for vegetarian softgels. As consumer preferences shift toward plant-based alternatives, Robinson Pharma continues to invest in vegetarian softgel technology, emphasizing the importance of expertise and consistent quality in this area.

The new Santa Ana facility adds 183,000 square feet of capacity and houses 20 manufacturing lines, enhancing the company’s capabilities in veggie softgel manufacturing to better serve client needs amid rising consumer demand for plant-based supplements. This facility represents a proactive approach to adapting to market trends while maintaining the scale and reliability expected by global brands.

Founded in 1989, Robinson Pharma has established itself as a significant player in the nutraceutical industry, recognized for its production capacity, competitive pricing, and adherence to quality standards. The company manufactures a wide range of dietary supplements, including softgels, veggie softgels, tablets, capsules, gummies, powders, and liquids, with a focus on custom formulations and packaging.